Stephen A. Hurly's most recent trade in LAVA Therapeutics NV was a trade of 335,100 Share Options (Right to Buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV | Stephen A. Hurly | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 335,100 | 335,100 | - | - | Share Options (Right to Buy) |